Up-regulation of SIRT1 has been reported in various human malignancies including breast cancer, prostate cancer, lymphoma, colon cancer, gastric cancer and hepatocellular carcinoma [9,28,29,31–34]. This evidence concerns the gene SIRT1 and prostate carcinoma.